4.4 Article

Prevalence and Mortality of Sarcopenia in a Community-dwelling Older Japanese Population: The Hisayama Study

Journal

JOURNAL OF EPIDEMIOLOGY
Volume 31, Issue 5, Pages 320-327

Publisher

JAPAN EPIDEMIOLOGICAL ASSOC
DOI: 10.2188/jea.JE20190289

Keywords

sarcopenia; Asian Working Group for Sarcopenia; prevalence; mortality

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [JP16H02692, JP16H05850, JP17H04126, JP18H02737, JP17K09114, JP17K09113, JP17K01853, JP18K07565, JP18K09412, JP19K07890, JP18K17925, JP18K17382]
  2. Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan [H29-Junkankitou-Ippan-003, H30-Shokuhin[Sitei]-005]
  3. Japan Agency for Medical Research and Development [JP19dk0207025, JP19ek0210082, JP19ek0210083, JP19km0405202, JP19ek0210080, JP19fk0108075]

Ask authors/readers for more resources

The prevalence of sarcopenia in community-dwelling older Japanese population was approximately 7%, with an increased mortality risk for subjects with sarcopenia. Our findings suggest the need for a public health strategy for sarcopenia to extend healthy life expectancy.
Background: The prevalence of sarcopenia defined using the Asian Working Group for Sarcopenia (AWGS) criteria in Asian communities has not been fully addressed. Moreover, few studies have addressed the influence of sarcopenia on mortality. Methods: A total of 1,371 and 1,597 residents aged 65 years or older participated in health surveys in 2012 and 2017. Sarcopenia was determined using the AWGS definition. Factors associated with the presence of sarcopenia were assessed using a logistic regression model in participants in the 2012 survey. Subjects in the 2012 survey were followed-up prospectively for a median of 4.3 years. Mortality risk for subjects with sarcopenia was examined using the Cox proportional hazards model. Results: The crude prevalence of sarcopenia was 7.4% and 6.6% in participants at the 2012 and 2017 surveys, respectively; there was no significant difference between surveys (P = 0.44). The prevalence of sarcopenia increased significantly with age in both sexes (both P for trend <0.001). Subjects with sarcopenia were more likely to exercise less regularly, to intake less total energy, and to exhibit a disability in activity of daily living than those without. The multivariable-adjusted hazard ratio for all-cause mortality was 2.20 (95% confidence interval, 1.25-3.85) in subjects with sarcopenia, compared to those without. Conclusions: Approximately 7% of older subjects had sarcopenia in a community-dwelling older Japanese population. Moreover, subjects with sarcopenia had an increased mortality risk. Our findings suggest that a public health strategy for sarcopenia is needed to extend healthy life expectancy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available